MYYNRIAH Trademark

Trademark Overview


On Monday, March 27, 2017, a trademark application was filed for MYYNRIAH with the United States Patent and Trademark Office. The USPTO has given the MYYNRIAH trademark a serial number of 79207198. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 12, 2024. This trademark is owned by NOVARTIS AG. The MYYNRIAH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations
myynriah

General Information


Serial Number79207198
Word MarkMYYNRIAH
Filing DateMonday, March 27, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 12, 2024
Registration Number5362100
Registration DateTuesday, December 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, May 16, 2017NON-FINAL ACTION WRITTEN
Thursday, May 11, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, May 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, May 14, 2017ASSIGNED TO EXAMINER
Thursday, June 1, 2017REFUSAL PROCESSED BY MPU
Thursday, June 1, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 31, 2017ASSIGNED TO LIE
Tuesday, September 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 4, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 4, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, May 17, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 17, 2017REFUSAL PROCESSED BY IB
Friday, July 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 26, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, April 2, 2018FINAL DISPOSITION PROCESSED
Monday, April 2, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 26, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 12, 2024CANCELLED SECTION 71
Saturday, May 19, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, October 21, 2017NOTIFICATION PROCESSED BY IB